Private Advisor Group, LLC Crispr Therapeutics Ag Transaction History

Private Advisor Group, LLC

$15.6 Billion
Q3 2024

A detailed history of Private Advisor Group, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Private Advisor Group, LLC holds 71,747 shares of CRSP stock, worth $3.12 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

71,747

Previous 77,627 7.57%

Holding current value

$3.12 Million

Previous $4.19 Million 19.58%

% of portfolio

0.02%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$44.62 - $62.75 $262,365 - $368,970	-5,880 Reduced 7.57%	71,747 $3.37 Million
Q2 2024 Aug 05, 2024	BUY	$51.17 - $68.18 $3.28 Million - $4.37 Million	64,076 Added 472.85%	77,627 $4.19 Million
Q1 2024 Apr 30, 2024	BUY	$60.67 - $89.12 $280,598 - $412,180	4,625 Added 51.81%	13,551 $923,000
Q4 2023 Feb 06, 2024	BUY	$38.62 - $72.18 $126,364 - $236,172	3,272 Added 57.87%	8,926 $558,000
Q3 2023 Nov 02, 2023	BUY	$45.39 - $59.0 $28,051 - $36,462	618 Added 12.27%	5,654 $256,000
Q2 2023 Aug 09, 2023	BUY	$43.47 - $67.77 $2,564 - $3,998	59 Added 1.19%	5,036 $282,000
Q1 2023 May 10, 2023	BUY	$41.0 - $56.12 $204,057 - $279,309	4,977 New	4,977 $225,000
Q3 2022 Oct 14, 2022	BUY	$61.1 - $83.78 $9,226 - $12,650	151 Added 2.48%	6,235 $407,000
Q2 2022 Jul 13, 2022	SELL	$43.23 - $73.83 $15,476 - $26,431	-358 Reduced 5.56%	6,084 $370,000
Q1 2022 May 12, 2022	SELL	$53.19 - $79.24 $266,747 - $397,388	-5,015 Reduced 43.77%	6,442 $404,000
Q4 2021 Feb 10, 2022	SELL	$70.09 - $111.29 $104,083 - $165,265	-1,485 Reduced 11.47%	11,457 $868,000
Q3 2021 Oct 14, 2021	BUY	$110.2 - $156.64 $339,746 - $482,921	3,083 Added 31.27%	12,942 $1.45 Million
Q2 2021 Aug 12, 2021	SELL	$100.84 - $161.89 $54,957 - $88,230	-545 Reduced 5.24%	9,859 $1.6 Million
Q1 2021 Apr 22, 2021	BUY	$110.72 - $210.04 $284,771 - $540,222	2,572 Added 32.84%	10,404 $1.27 Million
Q4 2020 Apr 01, 2021	BUY	$79.67 - $173.23 $266,575 - $579,627	3,346 Added 74.59%	7,832 $1.2 Million
Q3 2020 Nov 02, 2020	SELL	$78.5 - $100.64 $56,598 - $72,561	-721 Reduced 13.85%	4,486 $375,000
Q2 2020 Aug 17, 2020	BUY	$38.5 - $76.05 $13,090 - $25,857	340 Added 6.99%	5,207 $383,000
Q1 2020 May 12, 2020	SELL	$33.68 - $62.53 $95,381 - $177,084	-2,832 Reduced 36.78%	4,867 $206,000
Q4 2019 Feb 10, 2020	BUY	$36.68 - $73.13 $282,399 - $563,027	7,699 New	7,699 $469,000
Q3 2019 Nov 13, 2019	SELL	$40.99 - $52.56 $178,388 - $228,741	-4,352 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$35.45 - $48.2 $154,278 - $209,766	4,352 New	4,352 $205,000
Q4 2018 Feb 11, 2019	SELL	$22.73 - $42.34 $187,749 - $349,728	-8,260 Closed	0 $0
Q3 2018 Nov 01, 2018	BUY	$44.35 - $65.71 $198,909 - $294,709	4,485 Added 118.81%	8,260 $366,000
Q2 2018 Aug 09, 2018	BUY	$42.62 - $73.59 $160,890 - $277,802	3,775 New	3,775 $227,000

Others Institutions Holding CRSP

# of Institutions

486

Shares Held

57.9M

Call Options Held

1.09M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.39B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Account

Private Advisor Group, LLC Crispr Therapeutics Ag Transaction History